Results 21 to 30 of about 155 (122)
Using Intravenous Inmunoglobulin in an Atypical Case of Lambert Eaton Síndrome.
A 48 year-old hypertensive, smoker patient who started presenting a generalized weakness, pait instability,visual disorders and uncontrolled blood pressure is presented. At physical examination quadriparesis and weakness extraocular muscles were found. A
Erélido Hernández Valero +1 more
doaj +2 more sources
Vitiligo y terapia con inmunoglobulina intravenosa: a propósito de un paciente con síndrome de Sjögren [PDF]
Vitiligo is associated with other autoimmune diseases. We report a 52-year-old male with a Sjögren syndrome that was treated with monthly pulses of intravenous immunoglobulin for a chronicinflammatory demyelinating polyradiculoneuropathy. The neurological disorder responded adequately to the treatment and the patient also noted a marked remission of ...
Badilla P, Alejandro, Díaz G, Carolina
openaire +3 more sources
Necrolisis epidérmica tóxica. Terapia en UCI con inmunoglobulinas intravenosas en un caso
We report a 27 years old homosexual male with AIDS that was admitted to the ICU dehydrated, with fever and severe malaise. He had irregular bullae, an extensive purpuric exanthema and a zone of epidermic detachment in the right arm. A toxic epidermal necrolysis was diagnosed and therapy with i.v. immunoglobulins was started.
Andresen H, Max +4 more
openaire +3 more sources
Background: There is increasing evidence supporting that neuromyelitis optica (NMO) is an inflammatory humoral mediated disorder associated with NMO-IgG/AQP-4 antibodies.
C. de Andrés +4 more
doaj +1 more source
Resumen: Antecedentes: La neuromielitis óptica (NMO) es una enfermedad predominantemente humoral mediada por anticuerpos IgG-NMO/AQP-4. Sin embargo, no se conoce bien la contribución de las diferentes subpoblaciones de células B y T en su patogenia o en
C. de Andrés +4 more
doaj +1 more source
El mieloma múltiple en recaída y refractario continúa siendo un reto terapéutico, especialmente en pacientes expuestos a múltiples líneas previas.
Raquel Gracia Piquer +6 more
doaj +1 more source
Background: Intravenous immunoglobulin (IVIG) is the treatment of choice for humoral primary immunodeficiency diseases (PIDs). A third of the patients who receive intravenous immunoglobulin have adverse reactions, such as osmotic nephrosis.Objective: To assess the presence of kidney disease in adults with humoral PIDs, in treatment with intravenous ...
Patricia Maria O'Farrill-Romanillos +3 more
openaire +2 more sources
Insuficiencia hepática aguda por adenovirus tratada con inmunoglobulina intravenosa
Background: Acute liver failure in pediatric age is a serious multisystem disease, characterized by a failure of the synthesis and detoxification function of the liver. Among the etiologies, viral infection should be investigated. Treatment is supportive and some cases require liver transplantation. Case report: A 2-year-old girl was admitted for acute
Melissa Zavala Rodríguez +3 more
openaire +2 more sources
NUEVA TERAPIA CON INMUNOGLOBULINAS EN UN CASO DE HEMOCROMATOSIS NEONATAL
La hemocromatosis neonatal es una enfermedad hepática muy severa del recién nacido y se asocia a una alta mortalidad. Se cree que su etiología es de tipo aloinmune, debido a la presencia de un anticuerpo materno hasta ahora desconocido que interfiere con
Míreia Cruceyra Betriu +6 more
doaj
Opciones terapéuticas al síndrome de liberación de citocinas en pacientes con la COVID-19
Sin duda alguna la COVID-19 ha suscitado la atención de la población mundial durante el año 2020. La rápida propagación de la enfermedad, así como el número de contagios, complicaciones y muertes, constituyen los principales elementos distintivos de la ...
Urbano Solis Cartas +1 more
doaj

